Jefferies sets Eli Lilly price target to $814 By Investing.com
© Reuters.
On Wednesday, Eli Lilly (NYSE:) received an increased price target from an analyst at Jefferies, now set at $814.00, up from the previous target of $768.00. The firm has maintained a Buy rating on the pharmaceutical…